Zhao Z, Fei G, Miao T, Liu Y, Yang J, Liang Y
Sci Rep. 2025; 15(1):7746.
PMID: 40044781
PMC: 11882882.
DOI: 10.1038/s41598-025-92446-2.
Selvaraj R, Cioffi G, Waite K, Jackson S, Barnholtz-Sloan J
Cancers (Basel). 2025; 17(3).
PMID: 39941747
PMC: 11815994.
DOI: 10.3390/cancers17030378.
Silva J, Oliveira P, Duarte J, Faustino-Rocha A
In Vivo. 2024; 39(1):1-16.
PMID: 39740866
PMC: 11705154.
DOI: 10.21873/invivo.13800.
Yu M, Yin N, Feng B, Gao P, Yu K, Liu H
Sci Adv. 2024; 10(40):eadp0696.
PMID: 39356770
PMC: 11446276.
DOI: 10.1126/sciadv.adp0696.
Xega V, Liu J
Med Rev (2021). 2024; 4(4):284-300.
PMID: 39135604
PMC: 11317208.
DOI: 10.1515/mr-2024-0012.
Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells.
Cirillo F, Spinelli A, Talia M, Scordamaglia D, Santolla M, Grande F
J Transl Med. 2024; 22(1):450.
PMID: 38741146
PMC: 11089683.
DOI: 10.1186/s12967-024-05269-6.
Paxillin regulates androgen receptor expression associated with granulosa cell focal adhesions.
Weidner A, Roy A, Vann K, Walczyk A, Astapova O
Mol Hum Reprod. 2024; 30(5).
PMID: 38718206
PMC: 11136451.
DOI: 10.1093/molehr/gaae018.
Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in Mice.
Cheng J, Frye J, Whitman S, Ehsani S, Ali S, Funk J
Endocrinology. 2024; 165(6).
PMID: 38715255
PMC: 11076418.
DOI: 10.1210/endocr/bqae038.
Brain-derived neuerotrophic factor and related mechanisms that mediate and influence progesterone-induced neuroprotection.
Singh M, Krishnamoorthy V, Kim S, Khurana S, LaPorte H
Front Endocrinol (Lausanne). 2024; 15:1286066.
PMID: 38469139
PMC: 10925611.
DOI: 10.3389/fendo.2024.1286066.
A progesterone derivative linked to a stable phospholipid activates breast cancer cell response without leaving the cell membrane.
Font-Mateu J, Sanllehi P, Sot J, Abad B, Mateos N, Torreno-Pina J
Cell Mol Life Sci. 2024; 81(1):98.
PMID: 38386110
PMC: 10884080.
DOI: 10.1007/s00018-024-05116-3.
Sex-specific outcomes in cancer therapy: the central role of hormones.
Bakhshi P, Ho J, Zanganeh S
Front Med Technol. 2024; 6:1320690.
PMID: 38362126
PMC: 10867131.
DOI: 10.3389/fmedt.2024.1320690.
A plasma membrane-associated form of the androgen receptor enhances nuclear androgen signaling in osteoblasts and prostate cancer cells.
Kalyanaraman H, Casteel D, Pal China S, Zhuang S, Boss G, Pilz R
Sci Signal. 2024; 17(821):eadi7861.
PMID: 38289986
PMC: 10916501.
DOI: 10.1126/scisignal.adi7861.
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges.
Allard C, Cota D, Quarta C
Drugs. 2023; 84(2):127-148.
PMID: 38127286
DOI: 10.1007/s40265-023-01982-6.
Navigating a plethora of progesterone receptors: Comments on the safety/risk of progesterone supplementation in women with a history of breast cancer or at high-risk for developing breast cancer.
Diep C, Mauro L, Lange C
Steroids. 2023; 200:109329.
PMID: 37884178
PMC: 10842046.
DOI: 10.1016/j.steroids.2023.109329.
Peering into the Brain's Estrogen Receptors: PET Tracers for Visualization of Nuclear and Extranuclear Estrogen Receptors in Brain Disorders.
Arjmand S, Bender D, Jakobsen S, Wegener G, Landau A
Biomolecules. 2023; 13(9).
PMID: 37759805
PMC: 10526964.
DOI: 10.3390/biom13091405.
Lung cancer associated with combustion particles and fine particulate matter (PM) - The roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR).
Holme J, Vondracek J, Machala M, Lagadic-Gossmann D, Vogel C, Le Ferrec E
Biochem Pharmacol. 2023; 216:115801.
PMID: 37696458
PMC: 10543654.
DOI: 10.1016/j.bcp.2023.115801.
Mitogen-Activated Protein Kinase and Nuclear Hormone Receptor Crosstalk in Cancer Immunotherapy.
Burgermeister E
Int J Mol Sci. 2023; 24(17).
PMID: 37686465
PMC: 10488039.
DOI: 10.3390/ijms241713661.
Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma.
Zhang M, Yuan Y, Liu L, Wei Y, Yin W, Zheng L
World J Gastroenterol. 2023; 29(31):4706-4735.
PMID: 37664153
PMC: 10473924.
DOI: 10.3748/wjg.v29.i31.4706.
The impact of chromosomal sex on cardiometabolic health and disease.
Wiese C, Avetisyan R, Reue K
Trends Endocrinol Metab. 2023; 34(10):652-665.
PMID: 37598068
PMC: 11090013.
DOI: 10.1016/j.tem.2023.07.003.
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.
Burris T, de Vera I, Cote I, Flaveny C, Wanninayake U, Chatterjee A
Pharmacol Rev. 2023; 75(6):1233-1318.
PMID: 37586884
PMC: 10595025.
DOI: 10.1124/pharmrev.121.000436.